Artiva Biotherapeutics, Inc.

ARTV · Nasdaq · SIC 2836: Biological Products, (No Diagnostic Substances) · Market Cap: $0.2B · 104 employees
31
SEC Filings
$7.87
Close 2026-05-22
104
Employees

Business Summary

1 Item 1A. Risk Factors 48 Item 1B. Unresolved Staff Comments 117 Item 1C. Cybersecurity 117 Item 2. Properties 119 Item 3. Legal Proceedings 119 Item 4. Mine Safety Disclosures 119 PART II Item 5. Market for Registrants Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 120 Item 6. [Reserved] 121 Item 7. Managements Discussion and Analysis of Financial Condition and Results of Operations 122 Item 7A. Quantitative and Qualitative Disclosures About Market Risk 13...

Latest Stock Quote

ARTV 2026-05-22 $7.87 O:$7.97 H:$8.13 L:$7.7 Vol:0.3M VWAP:$7.8819
origin leaf: 835b8f946154e9e9671b576739449f076f66b5ea93819cb317b2bda2de40e53a

Next Earnings

Q2 FY2026 — expected 2026-08-18

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-102025-12-310001193125-26-100135EDGAR124K words
2025-03-242024-12-310000950170-25-043837EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-122025-09-300001193125-25-275872EDGAR80K words
2025-08-062025-06-300000950170-25-104045EDGAR—
2025-05-082025-03-310000950170-25-066421EDGAR—
2024-11-122024-09-300000950170-24-125382EDGAR—
2024-08-292024-06-300001193125-24-209924EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-100001193125-26-100131EDGAR2K words
2026-02-240001193125-26-067509EDGAR—
2026-02-190001193125-26-059716EDGAR—
2025-12-120001193125-25-317784EDGAR—
2025-11-120001193125-25-275902EDGAR—
2025-11-120001193125-25-275867EDGAR—
2025-08-060000950170-25-104028EDGAR—
2025-06-250000950170-25-089942EDGAR—
2025-05-080000950170-25-066416EDGAR—
2025-03-240000950170-25-043828EDGAR—

31 total filings indexed. 14 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

FDMT — 4D Molecular Therapeutics, Inc. APTN — ADAPTIN BIO, INC. ADMA — ADMA BIOLOGICS, INC. AGEN — AGENUS INC AIM — AIM ImmunoTech Inc. AMGN — AMGEN INC AVXL — ANAVEX LIFE SCIENCES CORP. ABPO — Abpro Holdings, Inc.

Company Identity

CIK0001817241
TickerARTV
ExchangeNasdaq
SIC2836: Biological Products, (No Diagnostic Substances)
IncorporatedDE
Websitehttps://www.artivabio.com
Listed2024-07-19

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: a0dcba4beba449114c872b93854d5b8ab6f6fc8141bf586d6f43672d94391c60
parent: d90ba931df0e24be6457006b720ca0a7f6eee7e6b435e6585869ad8573330ef4
content hash: bd9850001249b515b8e651fa3a2f82e0a94492b4cccf5d064d7834bd8ef5b78f
signed: 2026-06-02T19:00:15.685Z
sources: 8 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf